MannKind Corporation is a US-based biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products with diseases such as diabetes and pulmonary arterial hypertension. MannKind recently signed a collaboration and license agreement with Receptor Life Sciences, Inc., a biopharmaceutical company focused on cannabinoid medicines, to develop multiple undisclosed inhaled therapeutic compounds.
| Loading Documents... |
